Type to search

News

AstraZeneca cuts about 700 jobs, including 120 in Delaware

Avatar photo
Share

By Randall Chase, Associated Press

DOVER — British-based pharmaceutical company AstraZeneca says it is eliminating about 700 jobs in its U.S. commercial business, including about 120 at its North American headquarters in Wilmington.

The company said Thursday that the cuts also affect sales and non-sales positions across the United States, and include roughly 80 vacant positions.

The job cuts will leave AstraZeneca with about 1,500 employees in Delaware.

AstraZeneca, which once employed close to 5,000 workers in Delaware, announced in 2013 that it was cutting 1,200 jobs at its Wilmington headquarters.

In persuading AstraZeneca to select Wilmington over Pennsylvania as the site of its U.S. headquarters in 1999, then-Gov. Tom Carper offered the company about $50 million in state incentives, including 86 acres of state-owned land and tens of millions of dollars in tax credits.

Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.

Tags:

You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2022 Delaware Business Times

Holiday flash sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.

Holiday flash sale!

Subscribe to Delaware Business Times and save 50%

Limited time offer. New subscribers only.